Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease

INTRODUCTION: Synaptic dysfunction and degeneration is one of the earliest events in Alzheimer's disease (AD) and the best correlate of cognitive decline. Thus, identification and validation of biomarkers reflecting synaptic degeneration to be used as prognostic biomarkers are greatly needed. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsson, Johanna, Gobom, Johan, Sjödin, Simon, Brinkmalm, Gunnar, Ashton, Nicholas J., Svensson, Johan, Johansson, Per, Portelius, Erik, Zetterberg, Henrik, Blennow, Kaj, Brinkmalm, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cerebrospinal Fluid Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087978/
https://www.ncbi.nlm.nih.gov/pubmed/33969172
http://dx.doi.org/10.1002/dad2.12179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087978/
https://www.ncbi.nlm.nih.gov/pubmed/33969172
http://dx.doi.org/10.1002/dad2.12179

Ejemplares similares